Galapagos NV GXE.DE Stock
Galapagos NV Price Chart
Galapagos NV GXE.DE Financial and Trading Overview
| Galapagos NV stock price | 44.47 EUR |
| Previous Close | 44.47 EUR |
| Open | 44.18 EUR |
| Bid | 0 EUR x N/A |
| Ask | 0 EUR x N/A |
| Day's Range | 44.18 - 44.47 EUR |
| 52 Week Range | 41.7 - 66.4 EUR |
| Volume | 1 EUR |
| Avg. Volume | 62 EUR |
| Market Cap | 2.93B EUR |
| Beta (5Y Monthly) | 0.05977 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.921 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GXE.DE Valuation Measures
| Enterprise Value | -1025435904 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.3444676 |
| Price/Book (mrq) | 1.1497492 |
| Enterprise Value/Revenue | -1.872 |
| Enterprise Value/EBITDA | 5.624 |
Trading Information
Galapagos NV Stock Price History
| Beta (5Y Monthly) | 0.05977 |
| 52-Week Change | -10.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 66.4 EUR |
| 52 Week Low | 41.7 EUR |
| 50-Day Moving Average | 47.63 EUR |
| 200-Day Moving Average | 53.3 EUR |
GXE.DE Share Statistics
| Avg. Volume (3 month) | 62 EUR |
| Avg. Daily Volume (10-Days) | 4 EUR |
| Shares Outstanding | 65.84M |
| Float | 44.25M |
| Short Ratio | N/A |
| % Held by Insiders | 26.21% |
| % Held by Institutions | 32.02% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -33.12% |
| Operating Margin (ttm) | -36.091% |
| Gross Margin | 7.86% |
| EBITDA Margin | -33.28% |
Management Effectiveness
| Return on Assets (ttm) | -2.53% |
| Return on Equity (ttm) | -6.96% |
Income Statement
| Revenue (ttm) | 547.8M EUR |
| Revenue Per Share (ttm) | 8.35 EUR |
| Quarterly Revenue Growth (yoy) | 31.19% |
| Gross Profit (ttm) | 4.82M EUR |
| EBITDA | -182347008 EUR |
| Net Income Avi to Common (ttm) | -181474000 EUR |
| Diluted EPS (ttm) | -1.921 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.99B EUR |
| Total Cash Per Share (mrq) | 60.18 EUR |
| Total Debt (mrq) | 16M EUR |
| Total Debt/Equity (mrq) | 0.62 EUR |
| Current Ratio (mrq) | 7.947 |
| Book Value Per Share (mrq) | 38.678 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -533443008 EUR |
| Levered Free Cash Flow (ttm) | -137709632 EUR |
Profile of Galapagos NV
| Country | Germany |
| State | N/A |
| City | Mechelen |
| Address | Generaal De Wittelaan L11 A3 |
| ZIP | 2800 |
| Phone | 32 1 534 29 00 |
| Website | https://www.glpg.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1338 |
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of?various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG3667 that has completed Phase 1b trial; and GLPG5101 and GLPG5201, CD19 CAR-T product candidate manufactures at point-of-care, that is in Phase I/II in relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Q&A For Galapagos NV Stock
What is a current GXE.DE stock price?
Galapagos NV GXE.DE stock price today per share is 44.47 EUR.
How to purchase Galapagos NV stock?
You can buy GXE.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Galapagos NV?
The stock symbol or ticker of Galapagos NV is GXE.DE.
Which industry does the Galapagos NV company belong to?
The Galapagos NV industry is Biotechnology.
How many shares does Galapagos NV have in circulation?
The max supply of Galapagos NV shares is 65.84M.
What is Galapagos NV Price to Earnings Ratio (PE Ratio)?
Galapagos NV PE Ratio is now.
What was Galapagos NV earnings per share over the trailing 12 months (TTM)?
Galapagos NV EPS is -1.921 EUR over the trailing 12 months.
Which sector does the Galapagos NV company belong to?
The Galapagos NV sector is Healthcare.